A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities

A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities in Black Youth Living in the Deep South

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06428643

Enrollment

2322

Registered

2024-05-24

Start date

2025-08-14

Completion date

2029-09-01

Last updated

2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chlamydia, Gonorrhea, Hiv, Syphilis

Keywords

Screening, Expedited Treatment

Brief summary

This study includes testing for four STIs (chlamydia, gonorrhea, syphilis, and HIV) at no cost. If positive, individual subjects will also be counseled and offered options for treatment for themselves and their sex partners that may include no cost expedited treatment and the option to be rescreened 3 months after treatment.

Interventions

OTHERChlamydia, gonorrhea, syphilis, and HIV screening

Individuals aged 15-26 years old will be tested for chlamydia, gonorrhea, HIV, and syphilis at community based venues. Individuals who test positive for chlamydia and gonorrhea and their sexual partners will be offered expedited treatment at participating pharmacies. Individuals who test positive will be asked to be rescreened for Ct/GC at 3 months post treatment.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Masking

NONE

Masking description

None (Open Label)

Intervention model description

Community based screening of young men for chlamydia, gonorrhea, HIV, and syphilis. Expedited treatment for positive subjects and their sexual partners.

Eligibility

Sex/Gender

ALL

Age

15 Years to 26 Years

Healthy volunteers

Yes

Inclusion criteria

* Identifies as African American or Black * 15-26 years of age * Lives or spends most of their time in Orleans Parish * Had vaginal sex at least once

Exclusion criteria

* Unwilling or unable to provide informed consent * Unable to speak or understand English * Previously enrolled in the study * Known to be pregnant * Known HIV positive status

Design outcomes

Primary

Measure	Time frame	Description
Rate of chlamydia in women	up to 60 months	Primary outcome

Secondary

Measure	Time frame	Description
Rate of gonorrhea in women	up to 60 months	Secondary outcome

Countries

United States

Contacts

CONTACTPatricia Kissinger, PhD

kissing@tulane.edu504-988-7320

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026